- Home
- TERN vs NDMO Comparison
TERN vs NDMO Comparison
Compare TERN & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- NDMO
- Stock Information
- Founded
- TERN 2017
- NDMO 2019
- Country
- TERN United States
- NDMO United States
- Employees
- TERN N/A
- NDMO N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- NDMO Trusts Except Educational Religious and Charitable
- Sector
- TERN Health Care
- NDMO Finance
- Exchange
- TERN Nasdaq
- NDMO Nasdaq
- Market Cap
- TERN 634.5M
- NDMO 620.6M
- IPO Year
- TERN 2021
- NDMO N/A
- Fundamental
- Price
- TERN $8.30
- NDMO $10.44
- Analyst Decision
- TERN Buy
- NDMO
- Analyst Count
- TERN 6
- NDMO 0
- Target Price
- TERN $13.99
- NDMO N/A
- AVG Volume (30 Days)
- TERN 1.0M
- NDMO 218.6K
- Earning Date
- TERN 11-11-2025
- NDMO 01-01-0001
- Dividend Yield
- TERN N/A
- NDMO 6.75%
- EPS Growth
- TERN N/A
- NDMO N/A
- EPS
- TERN N/A
- NDMO N/A
- Revenue
- TERN N/A
- NDMO N/A
- Revenue This Year
- TERN N/A
- NDMO N/A
- Revenue Next Year
- TERN N/A
- NDMO N/A
- P/E Ratio
- TERN N/A
- NDMO N/A
- Revenue Growth
- TERN N/A
- NDMO N/A
- 52 Week Low
- TERN $1.87
- NDMO $8.99
- 52 Week High
- TERN $8.78
- NDMO $11.24
- Technical
- Relative Strength Index (RSI)
- TERN 57.97
- NDMO N/A
- Support Level
- TERN $7.45
- NDMO N/A
- Resistance Level
- TERN $8.77
- NDMO N/A
- Average True Range (ATR)
- TERN 0.41
- NDMO 0.00
- MACD
- TERN -0.00
- NDMO 0.00
- Stochastic Oscillator
- TERN 51.36
- NDMO 0.00
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest
Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.